Citeline Podcasts

Davinderpreet Mangat, Michael Haydock, and Andrew McConaghie discuss COVID-19 vaccines and hemophilia A & B gene therapies.

Topics covered in this episode include:

• COVID-19 next-generation vaccines (0:58)

• Hemophilia A & B gene therapies (32:40)

Scrip’s Five Must-Know Things – 31 May 2021 by Pharma Intelligence

This week’s podcast highlights Medtech Insight’s latest Market Intelligence report on continuous glucose monitors, a rapidly growing sector driven by innovation and patients’ demand for easier-to-use devices.

Scrip’s Five Must-Know Things – 24 May 2021 by Pharma Intelligence

In this week’s podcast, managing editor Elizabeth Orr and executive editor Shawn Schmitt discuss breaking news out of this year’s Medcon conference, sponsored by the FDA and Xavier University. Key topics include QSR harmonization, class II recalls, the new Inspectional Affairs Council, and the breakthrough pathway.

Pink Sheet reporters and editors discuss Emergent BioSolutions’ congressional appearance, plans for the next 21st Century Cures bill, and the FDA’s statement on the clinical trials for CytoDyn’s investigational COVID-19 therapy.

How the UK can manage its own device regulatory affairs outside the EU – either alone or with partners on selected areas of work.

In this month’s podcast, Medtech Insight's Reed Miller, Marion Webb and Barnaby Pickering offer a recap of Medtech Insight’s digital health coverage in April, including the digital transformation in the OR and clinical trials as well as remote monitoring.

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Market Intel: Medtechs, Surgeons Embrace ‘Virtual Operating Theater’ As New Reality

https://medtech.pharmaintelligence.informa.com/MT143839/Market-Intel-Medtechs-Surgeons-Embrace-Virtual-Operating-Theater-As-New-Reality

Smile Train And BioDigital Introduce App To Train Surgeons In Cleft Palate Repair

https://medtech.pharmaintelligence.informa.com/MT143840/Smile-Train-And-BioDigital-Introduce-App-To-Train-Surgeons-In-Cleft-Palate-Repair

Expert Panel Says Interoperability Remains Barrier In Digital Surgery Transformation

https://medtech.pharmaintelligence.informa.com/MT143910/Expert-Panel-Says-Interoperability-Remains-Barrier-In-Digital-Surgery-Transformation

FDA Authorizes GI Genius As A Smarter AI-Based Colonoscopy Tool

https://medtech.pharmaintelligence.informa.com/MT143777/FDA-Authorizes-GI-Genius-As-A-Smarter-AI-Based-Colonoscopy-Tool

Exec Chat: Manus Neurodynamica Will Augment Pharmaceutical Companies’ Drug Trials

https://medtech.pharmaintelligence.informa.com/MT143849/Exec-Chat-Manus-Neurodynamica-Will-Augment-Pharmaceutical-Companies-Drug-Trials

Exec Chat: Cumulus Neuroscience Help Trials Collect Previously Underutilized, Vital Data

https://medtech.pharmaintelligence.informa.com/MT143903/Exec-Chat-Cumulus-Neuroscience-Help-Trials-Collect-Previously-Underutilized-Vital-Data

ObvioHealth Is Building A New Digital Ecosystem To 'Revolutionize' Trials

https://medtech.pharmaintelligence.informa.com/MT143811/ObvioHealth-Is-Building-A-New-Digital-Ecosystem-To-Revolutionize-Trials

Report: Q1 Sets New Digital Health Investment Record, Telehealth Continues To Take Lion’s Share

https://medtech.pharmaintelligence.informa.com/MT143906/Report-Q1-Sets-New-Digital-Health-Investment-Record-Telehealth-Continues-To-Take-Lions-Share

Mayo Clinic Launches Two Companies To Support New Remote Monitoring Initiative

https://medtech.pharmaintelligence.informa.com/MT143786/Mayo-Clinic-Launches-Two-Companies-To-Support-New-Remote-Monitoring-Initiative

FDA Will No Longer Regulate Certain Medical Software

https://medtech.pharmaintelligence.informa.com/MT143802/FDA-Will-No-Longer-Regulate-Certain-Medical-Software

How To Win A Scrip Award 2021 by Pharma Intelligence

HBW Insight editors discuss the latest European consumer healthcare industry news. This week, Tom Gallen and David Ridley look at the Q1 financial results of four major Europe-based OTC players - GSK, Sanofi, Bayer and Reckitt - to analyse the impact that the coronavirus is still having on the region's consumer healthcare industry. An almost non-existent cough and cold season, due to lockdown measures, and last year's stockpiling of OTC drugs, have led to double-digit decreases in Q1 sales. A continuing trend for wellness and dietary supplements has offset some of the negative impacts of COVID-19, and, when the cough and cold season returns, points to a bright future for the European OTC market.